KCM
AVDL

Knoll Capital Management’s Avadel Pharmaceuticals AVDL Stock Holding History

Knoll Capital Management’s Portfolio AVDL Stock Details AVDL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-500,000
Closed -$4.58M – 28
2023
Q1 		$4.58M Buy
+500,000
New +$4.11M 7.06% 3

Other funds holding AVDL

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Knoll Capital Management's AVDL Position: Q1 2026 in Review

Knoll Capital Management sold out of Avadel Pharmaceuticals (AVDL) in Q1 2026, closing a stake of 600,000 shares — an estimated $12.9M sold.

Knoll Capital Management first reported a position in AVDL in Q4 2022 and held it in 12 quarters. The position peaked at $12.9M in Q4 2025. 2 funds tracked by Wall St. Rank hold AVDL as of Q1 2026.

  • Knoll Capital Management reported no remaining Avadel Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Knoll Capital Management sold 600,000 Avadel Pharmaceuticals shares in Q1 2026, an estimated $12.9M.
  • Knoll Capital Management first reported a position in Avadel Pharmaceuticals in Q4 2022 and held it in 12 quarters.
  • Knoll Capital Management's Avadel Pharmaceuticals position peaked at $12.9M in Q4 2025.
  • 2 funds tracked by Wall St. Rank held Avadel Pharmaceuticals as of Q1 2026.

Based on Knoll Capital Management's 13F filing for Q1 2026, filed 15 May 2026.